Oaktree Acquisition Corp. III Life Sciences (OACCU) Competitors $10.25 -0.10 (-0.97%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrendsBuy This Stock OACCU vs. ASPCU, AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, ANSCU, and AITRUShould you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include A SPAC III Acquisition (ASPCU), AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), Agriculture & Natural Solutions Acquisition (ANSCU), and AI Transportation Acquisition (AITRU). These companies are all part of the "trading" industry. Oaktree Acquisition Corp. III Life Sciences vs. A SPAC III Acquisition AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition Agriculture & Natural Solutions Acquisition AI Transportation Acquisition Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACCU) and A SPAC III Acquisition (NASDAQ:ASPCU) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, community ranking, dividends and analyst recommendations. Which has better valuation & earnings, OACCU or ASPCU? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/AA SPAC III AcquisitionN/AN/AN/AN/AN/A Is OACCU or ASPCU more profitable? Company Net Margins Return on Equity Return on Assets Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A A SPAC III Acquisition N/A N/A N/A Does the MarketBeat Community prefer OACCU or ASPCU? Oaktree Acquisition Corp. III Life Sciences and A SPAC III Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOaktree Acquisition Corp. III Life SciencesN/AN/AA SPAC III AcquisitionN/AN/A Does the media refer more to OACCU or ASPCU? In the previous week, Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 0.00 equaled A SPAC III Acquisition'saverage media sentiment score. Company Overall Sentiment Oaktree Acquisition Corp. III Life Sciences Neutral A SPAC III Acquisition Neutral SummaryOaktree Acquisition Corp. III Life Sciences and A SPAC III Acquisition tied by winning 0 of the 0 factors compared between the two stocks. Remove Ads Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for OACCU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OACCU vs. The Competition Export to ExcelMetricOaktree Acquisition Corp. III Life SciencesInvestment Offices IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$125.55M$10.21B$7.12BDividend YieldN/AN/A5.50%4.16%P/E RatioN/AN/A21.2717.47Price / SalesN/AN/A24.7787.93Price / CashN/AN/A17.6434.64Price / BookN/AN/A2.493.79Net IncomeN/AN/A$1.03B$247.35M7 Day Performance-0.53%0.96%-5.64%-6.48%1 Month Performance1.61%3.54%494.89%-10.82%1 Year PerformanceN/A34.82%530.92%-8.06% Oaktree Acquisition Corp. III Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACCUOaktree Acquisition Corp. III Life SciencesN/A$10.39+0.3%N/AN/A$0.00N/A0.00N/AASPCUA SPAC III AcquisitionN/A$10.21+0.3%N/AN/A$0.00N/A0.00N/AAGBAWAGBA GroupN/A$0.11+11.8%N/AN/A$0.00$38.55M0.00152Gap DownAGNCPAGNC InvestmentN/A$25.05-0.8%N/A+5.4%$0.00$973M0.0050AGNCOAGNC InvestmentN/A$25.16-1.7%N/A+1.6%$0.00$973M0.0050AGNCNAGNC InvestmentN/A$25.50-2.2%N/A-3.4%$0.00$973M0.0050AGNCMAGNC InvestmentN/A$24.95-1.4%N/A-0.8%$0.00$973M0.0050AGNCLAGNC InvestmentN/A$25.53-2.1%N/A+6.6%$0.00$973M0.0050Positive NewsANSCWAgriculture & Natural Solutions AcquisitionN/A$0.30flatN/AN/A$0.00N/A0.00N/AGap UpANSCUAgriculture & Natural Solutions AcquisitionN/A$10.79+1.2%N/AN/A$0.00N/A0.00N/AAITRUAI Transportation AcquisitionN/A$11.10-0.9%N/A+6.4%$0.00N/A0.00N/A Remove Ads Related Companies and Tools Related Companies ASPCU Competitors AGBAW Competitors AGNCP Competitors AGNCO Competitors AGNCN Competitors AGNCM Competitors AGNCL Competitors ANSCW Competitors ANSCU Competitors AITRU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OACCU) was last updated on 4/7/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
